Back to comparisons

Comparison

Modafinil vs Forskolin (Coleus forskohlii)

FieldModafinilForskolin (Coleus forskohlii)
Categorystimulantstimulant
Dose range100–200mg250–500mg
Half-life14h
Onset45min
EvidenceEVIDENCEAEVIDENCEB
Safety●●●○○●●●○○
Legal (US)USSchedule IVUSOTC
PubMed refs3200600

The comparison in plain English

Auto-generated from data

Modafinil and Forskolin (Coleus forskohlii) are both in the stimulant category respectively. Modafinil A eugeroic — a wakefulness-promoting compound — originally developed for narcolepsy. Forskolin (Coleus forskohlii) Diterpene from Coleus forskohlii root.

Bottom line

Modafinil (evidence A, safety 3/5) has a weaker evidence base than Forskolin (Coleus forskohlii) (evidence B, safety 3/5). Modafinil has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Modafinil if

Modafinil is the better fit when your goal aligns with its mechanism (Inhibits dopamine reuptake via the dopamine transporter (DAT), increasing extracellular dopamine in the prefrontal cortex) and the dose range (100–200mg) suits your protocol. Half-life is 14h.

Choose Forskolin (Coleus forskohlii) if

Forskolin (Coleus forskohlii) is the better fit when your goal aligns with its mechanism (Directly activates adenylyl cyclase, increasing intracellular cAMP) and the dose range (250–500mg) suits your protocol. Half-life is —h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →